Advertisement

Active identification of patients who are methicillin-resistant Staphylococcus aureus colonized is not associated with longer duration of vancomycin therapy

      Background

      Excessive prescribing of vancomycin among patients admitted to inpatient wards is a challenge for antimicrobial stewardship programs, especially in the setting of expanded screening programs for methicillin-resistant Staphylococcus aureus (MRSA). Studies examining factors associated with longer duration of vancomycin use are limited.

      Methods

      We conducted a retrospective cohort study to assess the impact of universal MRSA admission screening on duration of vancomycin use at the VA Boston Healthcare System during the period from January 2013-November 2015.

      Results

      A total of 2,910 patients were administered intravenous vancomycin during the study period. A clinical culture positive for MRSA was strongly associated with vancomycin administration lasting >72 hours (odds ratio [OR], 2.72; 95% confidence interval [CI], 1.86-3.97; P < .001). After controlling for clinical culture results, admission MRSA colonization was not associated with vancomycin use past 72 hours (OR, 0.94; 95% CI, 0.8-1.1). A negative MRSA nasal swab on admission had a high negative predictive value for all MRSA infections evaluated (99.6% for pneumonia, 99.6% for bloodstream infection, and 98.1% for skin and soft tissue infection).

      Conclusions

      Admission surveillance for MRSA nasal colonization is not a major driver of prolonged vancomycin use. A negative admission MRSA nasal screen may be a useful tool for antimicrobial stewardship programs to limit vancomycin use, particularly in noncritically ill patients.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Evans M.
        • Kralovic S.M.
        • Simbartl L.A.
        • Freberg R.W.
        • Obrosky D.S.
        • Roselle G.A.
        • et al.
        Veterans Affairs methicillin-resistant Staphylococcus aureus prevention initiative associated with a sustained reduction in transmissions and health care-associated infections.
        Am J Infect Control. 2013; 41: 1093-1095
        • Jain R.
        • Kralovic S.M.
        • Evans M.E.
        • Ambrose M.
        • Simbartl L.A.
        • Obrosky D.S.
        • et al.
        Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections.
        N Engl J Med. 2011; 364: 1419-1430
        • Muder R.R.
        • Cunningham C.
        • McCray E.
        • Squier C.
        • Perreiah P.
        • Jain R.
        • et al.
        Implementation of an industrial systems-engineering approach to reduce the incidence of methicillin-resistant Staphylococcus aureus infection.
        Infect Control Hosp Epidemiol. 2008; 29: 702-708
        • Evans M.E.
        • Kralovic S.M.
        • Simbartl L.A.
        • Jain R.
        • Roselle G.A.
        Eight years of decreased methicillin-resistant Staphylococcus aureus health care-associated infections associated with a Veterans Affairs prevention initiative.
        Am J Infect Control. 2017; 45: 13-16
        • Jones B.E.
        • Jones M.M.
        • Huttner B.
        • Stoddard G.
        • Brown K.A.
        • Stevens V.W.
        • et al.
        Trends in antibiotic use and nosocomial pathogens in hospitalized veterans with pneumonia at 128 medical centers, 2006-2010.
        Clin Infect Dis. 2015; 61: 1403-1410
        • Hospital Infection Control Practices Advisory Committee (HICPA)
        Recommendations for preventing the spread of vancomycin resistance.
        Infect Control Hosp Epidemiol. 1995; 16: 105-113
        • Johnson S.V.
        • Hoey L.L.
        • Vance-Bryan K.
        Inappropriate vancomycin prescribing based on criteria from the Centers for Disease Control and Prevention.
        Pharmacotherapy. 1995; 15: 579-585
        • Wright S.W.
        • Wrenn K.D.
        Appropriateness of vancomycin use in the emergency department.
        Ann Emerg Med. 1998; 32: 531-536
        • Junior M.S.
        • Correa L.
        • Marra A.R.
        • Camargo L.F.
        • Pereira C.A.
        Analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study.
        BMC Infect Dis. 2007; 7: 88
        • Evans M.E.
        • Kortas K.J.
        Vancomycin use in a university medical center: comparison with hospital infection control practices advisory committee guidelines.
        Infect Control Hosp Epidemiol. 1996; 17: 356-359
        • Jones M.
        • Huttner B.
        • Leecaster M.
        • Huttner A.
        • Damal K.
        • Tanner W.
        • et al.
        Does universal active MRSA surveillance influence anti-MRSA antibiotic use? A retrospective analysis of the treatment of patients admitted with suspicion of infection at Veterans Affairs Medical Centers between 2005 and 2010.
        J Antimicrob Chemother. 2014; 69: 3401-3408
        • Pulcini C.
        • Williams F.
        • Molinari N.
        • Davey P.
        • Nathwani D.
        Junior doctors' knowledge and perceptions of antibiotic resistance and prescribing: a survey in France and Scotland.
        Clin Microbiol Infect. 2011; 17: 80-87
        • Alzoubi K.
        • Ayoub N.
        • Al-Sakaji S.
        • Al-Azzam S.
        • Mhaidat N.
        • Masadeh M.
        Awareness of bacterial resistance among physicians, pharmacists and nurses.
        Int J Occup Med Environ Health. 2009; 22: 363-372
        • Kim N.-H.
        • Koo H.L.
        • Choe P.G.
        • Cheon S.
        • Kim M.S.
        • Lee M.J.
        • et al.
        Inappropriate continued empirical vancomycin use in a hospital with a high prevalence of methicillin-resistant Staphylococcus aureus.
        Antimicrob Agents Chemother. 2015; 59: 811-817
        • Butler-Laporte G.
        • Cheng M.P.
        • Cheng A.P.
        • McDonald E.G.
        • Lee T.C.
        Using MRSA screening tests to predict methicillin resistance in Staphylococcus aureus bacteremia.
        Antimicrob Agents Chemother. 2016; 60: 7444-7448
        • Honda H.
        • Krauss M.J.
        • Coopersmith C.M.
        • Kollef M.H.
        • Richmond A.M.
        • Fraser V.J.
        • et al.
        Staphylococcus aureus nasal colonization and subsequent infection in intensive care unit patients: does methicillin resistance matter?.
        Infect Control Hosp Epidemiol. 2010; 31: 584-591
        • Tilahun B.
        • Faust A.C.
        • McCorstin P.
        • Ortegon A.
        Nasal colonization and lower respiratory tract infections with methicillin-resistant Staphylococcus aureus.
        Am J Crit Care. 2015; 24: 8-12
        • Dangerfield B.
        • Chung A.
        • Webb B.
        • Seville M.T.
        Predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumonia.
        Antimicrob Agents Chemother. 2014; 58: 859-864
        • Johnson J.A.
        • Wright M.E.
        • Sheperd L.A.
        • Musher D.M.
        • Dang B.N.
        Nasal methicillin-resistant Staphylococcus aureus polymerase chain reaction: a potential use in guiding antibiotic therapy for pneumonia.
        Perm J. 2015; 19: 34-36
        • Sarikonda K.V.
        • Micek S.T.
        • Doherty J.A.
        • Reichley R.M.
        • Warren D.
        • Kollef M.H.
        Methicillin-resistant Staphylococcus aureus nasal colonization is a poor predictor of intensive care unit-acquired methicillin-resistant Staphylococcus aureus infections requiring antibiotic treatment.
        Crit Care Med. 2010; 38: 1991-1995
        • Hiett J.
        • Patel R.K.
        • Tate V.
        • Smulian G.
        • Kelly A.
        Using active methicillin-resistant Staphylococcus aureus surveillance nasal swabs to predict clinical respiratory culture results.
        Am J Health Syst Pharm. 2015; 72: S20-4
        • Gunderson C.G.
        • Holleck J.L.
        • Chang J.J.
        • Merchant N.
        • Lin S.
        • Gupta S.
        Diagnostic accuracy of methicillin-resistant Staphylococcus aureus nasal colonization to predict methicillin-resistant S aureus soft tissue infections.
        Am J Infect Control. 2016; 44: 1176-1177
        • Schleyer A.M.
        • Jarman K.M.
        • Chan J.D.
        • Dellit T.H.
        Role of nasal methicillin-resistant Staphylococcus aureus screening in the management of skin and soft tissue infections.
        Am J Infect Control. 2010; 38: 657-659
        • Stevens D.L.
        • Bisno A.L.
        • Chambers H.F.
        • Dellinger E.P.
        • Goldstein E.J.
        • Gorbach S.L.
        • et al.
        Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America.
        Clin Infect Dis. 2014; 59: e10-52